Literature DB >> 10930444

Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

D K Kaul1, R P Hebbel.   

Abstract

In sickle cell anemia, the initiation, progression, and resolution of a vasoocclusive episode may present features of ischemia-reperfusion injury, with recurrent episodes of ischemia/hypoxia and reoxygenation promoting inflammation. Here, we have tested the hypothesis that hypoxia/reoxygenation triggers inflammation in the transgenic sickle mouse. In these mice, even at ambient air, peripheral leukocyte counts are elevated by 1.7-fold and neutrophil counts by almost 3-fold. Two hours of hypoxia, followed by reoxygenation, induced a greater than normal rolling flux and adhesion of leukocytes in these mice, but no leukocyte extravasation. When 3 hours of hypoxia was followed by reoxygenation, sickle mice, but not normal mice, showed a distinct inflammatory response characterized by an increased number of adherent and emigrated leukocytes. Because these events, which are exaggerated in sickle mice, are not seen in response to hypoxia alone, we conclude that they represent a form of reperfusion injury. Studies using an H(2)O(2)-sensitive probe revealed clear evidence of oxidant production in vascular endothelial cells after hypoxia/reoxygenation in sickle mice. Infusion of an anti-P-selectin antibody, but not an anti-E-selectin antibody, completely inhibited this inflammatory response and significantly increased wall shear rates. These findings suggest that leukocyte-endothelium interaction contribute to vasoocclusive events in the sickle mice and perhaps in human sickle disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930444      PMCID: PMC314325          DOI: 10.1172/JCI9225

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

Review 1.  Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease.

Authors:  D N Granger
Journal:  Microcirculation       Date:  1999-09       Impact factor: 2.628

2.  On-line volume flow rate and velocity profile measurement for blood in microvessels.

Authors:  M Baker; H Wayland
Journal:  Microvasc Res       Date:  1974-01       Impact factor: 3.514

3.  The correlation of photometric signals derived from in vivo red blood cell flow in microvessels.

Authors:  J Silva; M Intaglietta
Journal:  Microvasc Res       Date:  1974-03       Impact factor: 3.514

4.  An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.

Authors:  S Baez
Journal:  Microvasc Res       Date:  1973-05       Impact factor: 3.514

5.  An unusual pattern of neutrophil kinetics in sickle cell anemia.

Authors:  D R Boggs; F Hyde; C Srodes
Journal:  Blood       Date:  1973-01       Impact factor: 22.113

Review 6.  Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.

Authors:  E Barrett-Connor
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

7.  Erythrocyte velocity measurement in microvessels by a two-slit photometric method.

Authors:  H Wayland; P C Johnson
Journal:  J Appl Physiol       Date:  1967-02       Impact factor: 3.531

8.  Reperfusion injury pathophysiology in sickle transgenic mice.

Authors:  U R Osarogiagbon; S Choong; J D Belcher; G M Vercellotti; M S Paller; R P Hebbel
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

9.  High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.

Authors:  M E Fabry; F Costantini; A Pachnis; S M Suzuka; N Bank; H S Aynedjian; S M Factor; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.

Authors:  M E Fabry; R L Nagel; A Pachnis; S M Suzuka; F Costantini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more
  131 in total

1.  Sickle cell anemia as an inflammatory disease.

Authors:  O S Platt
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

Authors:  Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Jeffrey C Kurz; Robert G Schaub; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

Review 3.  Vasculopathy and pulmonary hypertension in sickle cell disease.

Authors:  Karin P Potoka; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

4.  Effects of whole body vibration on outer hair cells' hearing response to distortion product otoacoustic emissions.

Authors:  Seyyed-Ali Moussavi-Najarkola; Ali Khavanin; Ramazan Mirzaei; Mojdeh Salehnia; Mehdi Akbari
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-05-02       Impact factor: 2.416

5.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

Review 6.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

7.  P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.

Authors:  Renata Polanowska-Grabowska; Kori Wallace; Joshua J Field; Lanlin Chen; Melissa A Marshall; Robert Figler; Adrian R L Gear; Joel Linden
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 8.  Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Authors:  Marilyn J Telen
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 9.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

10.  Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.

Authors:  Trisha Dasgupta; Mary E Fabry; Dhananjay K Kaul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.